Who owns Bright Minds Biosciences Inc.?
Institutional ownership of DRUG from SEC Form 13F filings across 74 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
74
13F holders
$321.6M
value, 2026 filers
46.9%
of shares outstanding (4.6M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of DRUG's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 1.3M | $94.8M | 0.0% | 13.8% | new |
| 2 | BlackRock, Inc. | 686,184 | $48.2M | 0.0% | 7% | +10.3% |
| 3 | Balyasny Asset Management L.P. | 345,053 | $24.2M | 0.0% | 3.5% | +16.1% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 335,000 | $23.5M | 0.0% | 3.4% | -32.4% |
| 5 | Point72 Asset Management, L.P.NEW | 327,416 | $23.0M | 0.0% | 3.3% | new |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 171,315 | $12.0M | 0.0% | 1.8% | +25.3% |
| 7 | GOLDMAN SACHS GROUP INC | 133,689 | $9.4M | 0.0% | 1.4% | +79.8% |
| 8 | SEVEN GRAND MANAGERS, LLC | 120,000 | $8.4M | 0.3% | 1.2% | 0.0% |
| 9 | GREAT POINT PARTNERS LLC | 109,603 | $7.7M | 1.5% | 1.1% | -50.2% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 104,146 | $7.3M | 0.0% | 1.1% | +17.4% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | 80,060 | $5.6M | 0.0% | 0.8% | +32.4% |
| 12 | Sio Capital Management, LLC | 73,952 | $5.2M | 0.9% | 0.8% | -14.1% |
| 13 | MILLENNIUM MANAGEMENT LLC | 66,740 | $4.7M | 0.0% | 0.7% | +26.3% |
| 14 | CITADEL ADVISORS LLCNEW | 66,533 | $4.7M | 0.0% | 0.7% | new |
| 15 | Schonfeld Strategic Advisors LLC | 66,277 | $4.7M | 0.0% | 0.7% | +400.4% |
| 16 | Walleye Capital LLC | 66,106 | $4.6M | 0.0% | 0.7% | -38.5% |
| 17 | Woodline Partners LP | 45,668 | $3.2M | 0.0% | 0.5% | -50.0% |
| 18 | NORTHERN TRUST CORP | 42,466 | $3.0M | 0.0% | 0.4% | +13.6% |
| 19 | AMERIPRISE FINANCIAL INC | 37,902 | $2.7M | 0.0% | 0.4% | -24.2% |
| 20 | LOS ANGELES CAPITAL MANAGEMENT LLCNEW | 35,747 | $2.5M | 0.0% | 0.4% | new |
| 21 | BOOTHBAY FUND MANAGEMENT, LLC | 27,870 | $2.0M | 0.0% | 0.3% | -45.7% |
| 22 | BANK OF AMERICA CORP /DE/ | 26,966 | $1.9M | 0.0% | 0.3% | +38.8% |
| 23 | MORGAN STANLEY | 18,599 | $1.3M | 0.0% | 0.2% | -86.0% |
| 24 | Sixth Street Partners Management Company, L.P.NEW | 18,032 | $1.3M | 0.2% | 0.2% | new |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 18,032 | $1.3M | 0.0% | 0.2% | +17.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.